Niagen Bioscience, Inc. (FRA:OCD1)
Germany · Delayed Price · Currency is EUR 5.70
+0.10 (1.79%)
At close: Nov 28, 2025
Niagen Bioscience Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
Net Income | 20.43 | 8.55 | -4.94 | -16.54 | -27.13 | -19.93 | Upgrade |
Depreciation & Amortization | 1.45 | 1.48 | 1.71 | 1.88 | 1.63 | 1.51 | Upgrade |
Loss (Gain) From Sale of Assets | 0 | -0.02 | -0.01 | 0.01 | - | - | Upgrade |
Asset Writedown & Restructuring Costs | - | - | 0 | - | - | 0.4 | Upgrade |
Stock-Based Compensation | 5.07 | 3.66 | 4.75 | 5.74 | 6.2 | 6.94 | Upgrade |
Provision & Write-off of Bad Debts | -2.56 | -1.26 | 0.96 | 0.06 | 0.05 | 0.04 | Upgrade |
Other Operating Activities | -3.47 | -3.44 | 0.08 | 0.07 | 0.11 | 0.09 | Upgrade |
Change in Accounts Receivable | 1.15 | -1.28 | 2.26 | -3.32 | -2.58 | -0.56 | Upgrade |
Change in Inventory | -8.25 | 5.33 | 0.15 | -1.08 | -1.92 | -0.15 | Upgrade |
Change in Accounts Payable | 6.48 | -1.07 | 0.55 | -0.74 | 0.98 | -0.18 | Upgrade |
Change in Unearned Revenue | 0.2 | -0.32 | -0.61 | -0.4 | -0.21 | 0.67 | Upgrade |
Change in Other Net Operating Assets | 0.9 | 0.46 | 2.21 | -0.78 | -1.28 | 0.56 | Upgrade |
Operating Cash Flow | 21.41 | 12.11 | 7.12 | -15.1 | -24.16 | -10.6 | Upgrade |
Operating Cash Flow Growth | 412.77% | 70.14% | - | - | - | - | Upgrade |
Capital Expenditures | -0.26 | -0.16 | -0.15 | -0.33 | -0.41 | -0.12 | Upgrade |
Sale of Property, Plant & Equipment | - | 0.02 | 0.01 | - | - | - | Upgrade |
Sale (Purchase) of Intangibles | - | - | - | - | - | -0.02 | Upgrade |
Other Investing Activities | - | - | - | - | - | -0.02 | Upgrade |
Investing Cash Flow | -0.26 | -0.14 | -0.14 | -0.33 | -0.41 | -0.17 | Upgrade |
Long-Term Debt Repaid | - | -0.01 | -0.02 | -0.02 | -0.03 | -0.27 | Upgrade |
Net Debt Issued (Repaid) | -0.01 | -0.01 | -0.02 | -0.02 | -0.03 | -0.27 | Upgrade |
Issuance of Common Stock | 10.81 | 5.43 | - | 7.75 | 36.24 | 8.97 | Upgrade |
Other Financing Activities | -0.05 | -0.05 | -0.08 | -0.08 | -0.11 | -0.05 | Upgrade |
Financing Cash Flow | 10.74 | 5.37 | -0.09 | 7.65 | 36.09 | 8.65 | Upgrade |
Net Cash Flow | 31.89 | 17.34 | 6.88 | -7.78 | 11.52 | -2.12 | Upgrade |
Free Cash Flow | 21.15 | 11.95 | 6.97 | -15.43 | -24.57 | -10.72 | Upgrade |
Free Cash Flow Growth | 420.89% | 71.42% | - | - | - | - | Upgrade |
Free Cash Flow Margin | 16.96% | 11.99% | 8.34% | -21.42% | -36.43% | -18.10% | Upgrade |
Free Cash Flow Per Share | 0.25 | 0.15 | 0.09 | -0.22 | -0.37 | -0.18 | Upgrade |
Cash Interest Paid | 0 | 0 | 0 | 0 | 0 | 0.01 | Upgrade |
Levered Free Cash Flow | 13.79 | 9.61 | 9.47 | -9.64 | -13.5 | -3.32 | Upgrade |
Unlevered Free Cash Flow | 13.79 | 9.61 | 9.47 | -9.64 | -13.46 | -3.27 | Upgrade |
Change in Working Capital | 0.48 | 3.13 | 4.56 | -6.32 | -5.01 | 0.35 | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.